Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12616000252415Phase 4Completed
Phase 4, randomised, open-label trial of hetastarch in pregnancy, sponsored by Guanghan Pharmaceutical. Primary endpoints: Cardiac output, Mean arterial pressure and 1 more. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12616000252415.